This article provides a comprehensive analysis of the challenges associated with Variants of Uncertain Significance (VUS) in clinical Whole Exome Sequencing (WES).
This article provides a comprehensive resource for researchers and drug developers on implementing Cas13d for precise, isoform-specific RNA knockdown.
This article provides a comprehensive, up-to-date guide for researchers aiming to leverage CRISPR/Cas9 for targeted mutagenesis in Nucleotide-Binding Site (NBS) genes.
This comprehensive guide for researchers, scientists, and drug development professionals explores the pivotal role of CRISPR/Cas9 technology in studying and correcting disease-causing alternative splicing mutations.
This article provides a comprehensive comparison for researchers, scientists, and drug development professionals between the novel CRISPR-Select workflow and traditional clonal analysis methods like limiting dilution.
This article provides a complete framework for researchers and drug development professionals to implement CRISPR-Select methodologies for the functional annotation of genetic variants.
This article provides a complete framework for implementing CRISPR-Select technology, an advanced tool for high-throughput functional analysis of genetic variants.
This comprehensive guide provides researchers and drug development professionals with a detailed, current protocol for using CRISPR-Cas9 to functionally validate genetic variants.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on using CRISPR-Cas9 for the functional validation of Variants of Uncertain Significance (VUS).
This article provides a detailed, comparative analysis of CRISPR-Cas and TALEN technologies for gene validation, focusing on specificity, which is critical for reliable functional genomics and therapeutic development.